ACLS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Formby, B
Right arrow Articles by Shao, T
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Formby, B
Right arrow Articles by Shao, T
Annals of Clinical and Laboratory Science, Vol 23, Issue 2, 137-147
Copyright © 1993 by Association of Clinical Scientists


Articles

T cell vaccination against autoimmune diabetes in nonobese diabetic mice

B Formby and T Shao

The diabetogenic autoimmune process was accelerated in 23 days nonirradiated postnatal nonobese diabetic (NOD) female mice by adoptive transfer of pathogenic, polyclonal CD4+ 8- T cells isolated from diabetic spleens. Recipient mice developed hyperglycemia 15 days after transfer of pathogenic immune cells with typical histological signs of pancreatic infiltration. The CD4+V beta 8+ T cells isolated from diabetic spleens and activated by surface-immobilized anti-TCRV beta 8 monoclonal antibody (mAb, clone F23.1) induced suppression of a diabetogenic disease process accelerated earlier by adoptively transferred polyclonal CD4+8- T cells. When CD4+V beta 8+ T cells isolated from diabetic spleens were activated by cross-linking TCRV beta 8 and systemically injected into young female NOD mice, an endogenous immunosuppressive circuit was stimulated that completely prevented development of insulitis and disease. A suppressor mechanism involving CD8+ T cells might be involved since in vitro these cells strongly proliferated in response to irradiated CD4+ V beta 8+ T cells that in blocking experiments with specific mAb was found to be class I major histocompatibility complex (MHC)-restricted. Hence, T cells expressing the CD8 phenotype specifically respond to idiotypic or ergotypic determinants on the inducing activated CD4+V beta 8+ T cells and effectively suppress a diabetogenic disease process by a mechanism that may involve T-T cell interactions.


This article has been cited by other articles:


Home page
LupusHome page
Z-G Li, R Mu, Z-P Dai, and X-M Gao
T cell vaccination in systemic lupus erythematosus with autologous activated T cells
Lupus, November 1, 2005; 14(11): 884 - 889.
[Abstract] [PDF]


Home page
J. Immunol.Home page
J. A. M. Borghans, R. J. De Boer, E. Sercarz, and V. Kumar
T Cell Vaccination in Experimental Autoimmune Encephalomyelitis: A Mathematical Model
J. Immunol., August 1, 1998; 161(3): 1087 - 1093.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the Association of Clinical Scientists.